The effect of the gastrectomy on survival in patients with metastatic gastric cancer: a study of ASMO

Basit Öğe Kaydı
dc.authoridElkıran, Emin Tamer/0000-0001-6681-7249
dc.authoridAksoy, Sercan/0000-0003-4984-1049
dc.authoridCicin, Irfan/0000-0002-7584-3868
dc.authoridGöksel, Gamze/0000-0002-7991-0036
dc.authoridHacıbekiroğlu, İlhan/0000-0002-0333-7405
dc.authoridUysal, Mukremin/0000-0002-8524-0665
dc.authoridduran, Ayse Ocak/0000-0002-1703-726X
dc.authorwosidElkıran, Emin Tamer/ABI-8192-2020
dc.authorwosidZengin, Nurullah/KBQ-0049-2024
dc.authorwosidAksoy, Sercan/S-2480-2019
dc.authorwosidCicin, Irfan/AAQ-5575-2020
dc.authorwosidGöksel, Gamze/HHC-6548-2022
dc.authorwosidHacıbekiroğlu, İlhan/JCN-7264-2023
dc.authorwosidUysal, Mukremin/B-8956-2014
dc.contributor.authorYazici, Ozan
dc.contributor.authorOzdemir, Nuriye
dc.contributor.authorDuran, Ayse Ocak
dc.contributor.authorMenekse, Serkan
dc.contributor.authorAli, Mehmet
dc.contributor.authorSendur, Nahit
dc.contributor.authorKaraca, Halit
dc.date.accessioned2024-06-12T10:50:52Z
dc.date.available2024-06-12T10:50:52Z
dc.date.issued2016
dc.departmentTrakya Üniversitesien_US
dc.description.abstractAim: To investigate the role of surgical resection of primary tumor on overall survival (OS) in advanced gastric cancer patients at the time of diagnosis. Patients & methods: The survival rates of metastatic gastric cancer patients whose gastric primary tumor was resected at time of diagnosis were compared with metastatic gastric cancer patients whose primary tumor was nonresected. Results: The median progression-free survival and OS in operated and nonoperated group were 10 versus 6, 14 versus 9 months, respectively (p < 0.001). In multivariate analysis, gastric resection of primary tumor, Eastern Cooperative Oncology Group performance status, second-line chemotherapy had a significant effect on OS (hazard ratio [HR]: 0.52 [95% CI: 0.38-0.71], HR: 0.57 [95% CI: 0.42-0.78], HR: 1.48 [1.09-2.01]; p <= 0.001, p = 0.001 and p = 0.012, respectively). Conclusion: Subpopulations of patients with metastatic gastric cancer might benefit from surgical removal of primary tumor.en_US
dc.identifier.doi10.2217/fon.15.304
dc.identifier.endpage354en_US
dc.identifier.issn1479-6694
dc.identifier.issn1744-8301
dc.identifier.issue3en_US
dc.identifier.pmid26775722en_US
dc.identifier.scopus2-s2.0-84956466822en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage343en_US
dc.identifier.urihttps://doi.org/10.2217/fon.15.304
dc.identifier.urihttps://hdl.handle.net/20.500.14551/18162
dc.identifier.volume12en_US
dc.identifier.wosWOS:000368937200011en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherFuture Medicine Ltden_US
dc.relation.ispartofFuture Oncologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAdvanced Gastric Canceren_US
dc.subjectGastrectomyen_US
dc.subjectResectionen_US
dc.subjectSurvivalen_US
dc.subjectRenal-Cell Carcinomaen_US
dc.subjectPalliative Gastrectomyen_US
dc.subjectCytoreductive Nephrectomyen_US
dc.subjectPlus Fluorouracilen_US
dc.subjectPhase-Iiien_US
dc.subjectResectionen_US
dc.subjectCisplatinen_US
dc.subjectSurgeryen_US
dc.subjectChemotherapyen_US
dc.subjectExperienceen_US
dc.titleThe effect of the gastrectomy on survival in patients with metastatic gastric cancer: a study of ASMOen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu